DARPins as Bispecific Receptor Antagonists Analyzed for Immunoglobulin E Receptor Blockage
Authors:
- Alexander EggelAEAlexander Eggel
- Michael J. BaumannMBMichael J. Baumann
- Patrick AmstutzPAPatrick Amstutz
- Beda M. StadlerBSBeda M. Stadler
- Monique VogelMVMonique Vogel
- 1 October 2009
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 393 (3) , 598-607
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Recombinant approaches to IgG-like bispecific antibodiesActa Pharmacologica Sinica, 2005
- A revival of bispecific antibodiesTrends in Biotechnology, 2004
- Structural insights into the interactions between human IgE and its high affinity receptor FcεRIMolecular Immunology, 2002
- Conditional autoimmunity mediated by human natural anti‐FcεRIα autoantibodies?The FASEB Journal, 2001
- THE HIGH-AFFINITY IgE RECEPTOR (FcεRI): From Physiology to PathologyAnnual Review of Immunology, 1999
- Human anti-FcεRIα autoantibodies isolated from healthy donors cross-react with tetanus toxoidEuropean Journal of Immunology, 1999
- THE CRYSTAL STRUCTURE OF THE HUMAN HIGH-AFFINITY IgE RECEPTOR (FcεRIα)Annual Review of Immunology, 1999
- The membrane‐proximal part of FcϵRIα contributes to human IgE and antibody binding – implications for a general structural motif in Fc receptorsFEBS Letters, 1998
- A hapten-specific chimaeric IgE antibody with human physiological effector functionNature, 1985